Center for Infectious Disease Research and Policy, University of Minnesota, Minneapolis, Minnesota, USA.
mBio. 2012 Feb 24;3(2):e00045-12. doi: 10.1128/mBio.00045-12. Print 2012.
Two recently submitted (but as yet unpublished) studies describe success in creating mutant isolates of H5N1 influenza A virus that can be transmitted via the respiratory route between ferrets; concern has been raised regarding human-to-human transmissibility of these or similar laboratory-generated influenza viruses. Furthermore, the potential release of methods used in these studies has engendered a great deal of controversy around publishing potential dual-use data and also has served as a catalyst for debates around the true case-fatality rate of H5N1 influenza and the capability of influenza vaccines and antivirals to impact any future unintentional or intentional release of H5N1 virus. In this report, we review available seroepidemiology data for H5N1 infection and discuss how case-finding strategies may influence the overall case-fatality rate reported by the WHO. We also provide information supporting the position that if an H5N1 influenza pandemic occurred, available medical countermeasures would have limited impact on the associated morbidity and mortality.
两篇最近提交(但尚未公布)的研究描述了成功创建可通过呼吸道在雪貂间传播的 H5N1 流感 A 病毒突变株的情况;人们担心这些或类似的实验室产生的流感病毒是否具有在人与人之间传播的能力。此外,这些研究中使用的方法的潜在释放引发了大量关于发表潜在两用数据的争议,也成为围绕 H5N1 流感的真实病死率以及流感疫苗和抗病毒药物对任何未来意外或故意释放 H5N1 病毒的影响的争论的催化剂。在本报告中,我们回顾了 H5N1 感染的现有血清流行病学数据,并讨论了病例发现策略如何影响世卫组织报告的总病死率。我们还提供了支持以下观点的信息:如果发生 H5N1 流感大流行,现有的医疗对策将对相关发病率和死亡率产生有限的影响。